Cargando…

Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma

BACKGROUND: The aim of this study was to investigate inequalities in survival for non-Hodgkin’s lymphoma (NHL), distinguishing between direct and indirect effects of patient, social and process-of-care factors. METHODS: All cases of NHL diagnosed in Ireland in 2004–2008 were included. Variables desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Comber, Harry, De Camargo Cancela, Marianna, Haase, Trutz, Johnson, Howard, Sharp, Linda, Pratschke, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167407/
https://www.ncbi.nlm.nih.gov/pubmed/27992551
http://dx.doi.org/10.1371/journal.pone.0168684
_version_ 1782483174513704960
author Comber, Harry
De Camargo Cancela, Marianna
Haase, Trutz
Johnson, Howard
Sharp, Linda
Pratschke, Jonathan
author_facet Comber, Harry
De Camargo Cancela, Marianna
Haase, Trutz
Johnson, Howard
Sharp, Linda
Pratschke, Jonathan
author_sort Comber, Harry
collection PubMed
description BACKGROUND: The aim of this study was to investigate inequalities in survival for non-Hodgkin’s lymphoma (NHL), distinguishing between direct and indirect effects of patient, social and process-of-care factors. METHODS: All cases of NHL diagnosed in Ireland in 2004–2008 were included. Variables describing patient, cancer, stage and process of care were included in a discrete-time model of survival using Structural Equation Modelling software. RESULTS: Emergency admissions were more common in patients with co-morbid conditions or with more aggressive cancers, and less frequent for patients from more affluent areas. Aggressive morphology, female sex, emergency admission, increasing age, comorbidity, treatment in a high caseload hospital and late stage were associated with increased hazard of mortality. Private patients had a reduced hazard of mortality, mediated by systemic therapy, admission to high caseload hospitals and fewer emergency admissions. DISCUSSION: The higher rate of emergency presentation, and consequent poorer survival, of uninsured patients, suggests they face barriers to early presentation. Social, educational and cultural factors may also discourage disadvantaged patients from consulting with early symptoms of NHL. Non-insured patients, who present later and have more emergency admissions would benefit from better access to diagnostic services. Older patients remain disadvantaged by sub-optimal treatment, treatment in non-specialist centres and emergency admission.
format Online
Article
Text
id pubmed-5167407
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51674072017-01-04 Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma Comber, Harry De Camargo Cancela, Marianna Haase, Trutz Johnson, Howard Sharp, Linda Pratschke, Jonathan PLoS One Research Article BACKGROUND: The aim of this study was to investigate inequalities in survival for non-Hodgkin’s lymphoma (NHL), distinguishing between direct and indirect effects of patient, social and process-of-care factors. METHODS: All cases of NHL diagnosed in Ireland in 2004–2008 were included. Variables describing patient, cancer, stage and process of care were included in a discrete-time model of survival using Structural Equation Modelling software. RESULTS: Emergency admissions were more common in patients with co-morbid conditions or with more aggressive cancers, and less frequent for patients from more affluent areas. Aggressive morphology, female sex, emergency admission, increasing age, comorbidity, treatment in a high caseload hospital and late stage were associated with increased hazard of mortality. Private patients had a reduced hazard of mortality, mediated by systemic therapy, admission to high caseload hospitals and fewer emergency admissions. DISCUSSION: The higher rate of emergency presentation, and consequent poorer survival, of uninsured patients, suggests they face barriers to early presentation. Social, educational and cultural factors may also discourage disadvantaged patients from consulting with early symptoms of NHL. Non-insured patients, who present later and have more emergency admissions would benefit from better access to diagnostic services. Older patients remain disadvantaged by sub-optimal treatment, treatment in non-specialist centres and emergency admission. Public Library of Science 2016-12-19 /pmc/articles/PMC5167407/ /pubmed/27992551 http://dx.doi.org/10.1371/journal.pone.0168684 Text en © 2016 Comber et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Comber, Harry
De Camargo Cancela, Marianna
Haase, Trutz
Johnson, Howard
Sharp, Linda
Pratschke, Jonathan
Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
title Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
title_full Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
title_fullStr Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
title_full_unstemmed Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
title_short Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin’s Lymphoma
title_sort affluence and private health insurance influence treatment and survival in non-hodgkin’s lymphoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167407/
https://www.ncbi.nlm.nih.gov/pubmed/27992551
http://dx.doi.org/10.1371/journal.pone.0168684
work_keys_str_mv AT comberharry affluenceandprivatehealthinsuranceinfluencetreatmentandsurvivalinnonhodgkinslymphoma
AT decamargocancelamarianna affluenceandprivatehealthinsuranceinfluencetreatmentandsurvivalinnonhodgkinslymphoma
AT haasetrutz affluenceandprivatehealthinsuranceinfluencetreatmentandsurvivalinnonhodgkinslymphoma
AT johnsonhoward affluenceandprivatehealthinsuranceinfluencetreatmentandsurvivalinnonhodgkinslymphoma
AT sharplinda affluenceandprivatehealthinsuranceinfluencetreatmentandsurvivalinnonhodgkinslymphoma
AT pratschkejonathan affluenceandprivatehealthinsuranceinfluencetreatmentandsurvivalinnonhodgkinslymphoma